相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of mutant p53 in human cancer
Amanda M. Goh et al.
JOURNAL OF PATHOLOGY (2011)
Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation immunoassay
Qun Huo
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Adriano Aguzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Drug discovery and mutant p53
Magda M. Maslon et al.
TRENDS IN CELL BIOLOGY (2010)
Structural biology of the p53 tumour suppressor
Andrei L. Okorokov et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)
MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
Jan-Philipp Kruse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural evolution of p53, p63, and p73: Implication for heterotetramer formation
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Molecular chaperones as regulators of cell death
A. Hishiya et al.
ONCOGENE (2008)
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers
Chee-Onn Leong et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors
Lakshmanane Boominathan
MOLECULAR CANCER (2007)
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Y. Li et al.
ONCOGENE (2007)
p53 family members in myogenic differentiation and rhabdomyosarcoma development
Hakan Cam et al.
CANCER CELL (2006)
Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains
Hwee Ching Ang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The FoldX web server: an online force field
J Schymkowitz et al.
NUCLEIC ACIDS RESEARCH (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Tumor predisposition in mice mutant for p63 and p73:: Evidence for broader tumor suppressor functions for the p53 family
ER Flores et al.
CANCER CELL (2005)
How many mutant p53 molecules are needed to inactivate a tetramer?
WM Chan et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
AM Fernandez-Escamilla et al.
NATURE BIOTECHNOLOGY (2004)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Fibrillar aggregates of the tumor suppressor p53 core domain
D Ishimaru et al.
BIOCHEMISTRY (2003)
Change of conformation of the DNA-binding domain of p53 is the only key element for binding of and interference with p73
K Bensaad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prognostic significance of P53 mutations in colon cancer at the population level
WS Samowitz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
Specificity in intracellular protein aggregation and inclusion body formation
RS Rajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Physical and functional interaction between p53 mutants and different isoforms of p73
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
AN Bullock et al.
ONCOGENE (2000)
分享论文
